This listing is not intended to be exhaustive, but rather provides a guide
[[Page 15866]]
for readers regarding entities likely to be affected by this action. Other types of entities not listed in this unit could also be affected. The North American Industrial Classification System (NAICS) codes have been provided to assist you and others in determining whether this action might apply to certain entities. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT. B. How Can I Access Electronic Copies of this Document?

In addition to accessing electronically available documents at http://www.regulations.gov, you may access this Federal Register document electronically through the EPA Internet under the ``Federal Register'' listings at http://www.epa.gov/fedrgstr. You may also access a frequently updated electronic version of 40 CFR part 180 through the Government Printing Office's eCFR site at http://www.gpoaccess.gov/ ecfr.

C. Can I File an Objection or Hearing Request?

Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file an objection to any aspect of this regulation and may also request a hearing on those objections. The EPA procedural regulations which govern the submission of objections and requests for hearings appear in 40 CFR part 178. You must file your objection or request a hearing on this regulation in accordance with the instructions provided in 40 CFR part 178. To ensure proper receipt by EPA, you must identify docket ID number EPAHQOPP20080762 in the subject line on the first page of your submission. All requests must be in writing, and must be mailed or delivered to the Hearing Clerk on or before June 8, 2009.

In addition to filing an objection or hearing request with the Hearing Clerk as described in 40 CFR part 178, please submit a copy of the filing that does not contain any CBI for inclusion in the public docket that is described in ADDRESSES. Information not marked confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA without prior notice. Submit your copies, identified by docket ID number EPAHQOPP20080762, by one of the following methods.

In the Federal Register of November 14, 2008 (73 FR 67512) (FRL 83883), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21 U.S.C. 346a(d)(3), announcing the filing of a pesticide tolerance petition (PP 8F7368) by Becker Underwood, Inc., 801 Dayton Ave., P. O. Box 667, Ames, IA 50010. The petition requested that 40 CFR 180.1128 be amended by expanding the existing exemption from the requirement of a tolerance for the biofungicide Bacillus subtilis MBI 600 to cover residues in or on all food commodities, including residues resulting from postharvest uses. The notice included a summary of the petition prepared by the petitioner Becker Underwood, Inc.

Previously, on June 8, 1994 (59 FR 29543) (FRL48658), EPA issued a final rule granting an exemption from the requirement of a tolerance for residues of Bacillus subtilis MBI 600 in or on all raw agricultural commodities when applied as a seed treatment on seeds used for growing agricultural crops. In submitting this current petition (i.e., 8F7368), Becker Underwood, Inc. is relying on the data previously submitted by another company, Gustafson, Inc., in support of the existing tolerance exemption for Bacillus subtilis MBI 600. These data were previously summarized by EPA in the June 8, 1994, final rule. On July 18, 2002, EPA issued a Tolerance Reassessment Decision in which it found that the existing tolerance exemption for Bacillus subtilis MBI 600 continues to meet the FQPA safety standard. This determination in 2002 was based on EPA's review of the data on which Becker Underwood, Inc., is now relying in connection with this action.

There was one comment received in response to the notice of filing. The commenter expressed dissatisfaction with the level of safety EPA provides to Americans. Pursuant to its authority under the FFDCA, EPA conducted a comprehensive assessment of Bacillus subtilis MBI 600, including a review of studies addressing acute oral, pulmonary and intravenous injection toxicity/pathogenicity; acute dermal toxicity; primary eye irritation: and skin sensitization. EPA review of these studies indicated that the active ingredient is not toxic to test animals when administered via the oral, pulmonary, intravenous or dermal routes of exposure. In addition, the active ingredient was not infective or pathogenic to test animals when administered via the oral, pulmonary or intravenous routes. Moreover, no reports of
hypersensitivity have been recorded in personnel working with this organism. Based on these data, the Agency has concluded that there is a reasonable certainty that no harm will result from dietary exposure to residues of Bacillus subtilis MBI 600 in or on all food commodities, including residues resulting from postharvest uses. Thus, under the standard in FFDCA section 408(c)(2), an exemption from the requirement of a tolerance is appropriate.

Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an exemption from the requirement for a tolerance (the legal limit for a pesticide chemical residue in or on a food) only if EPA determines that the exemption is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a reasonable certainty that no harm will result from aggregate exposure to the pesticide chemical residue, including all anticipated dietary exposures and all other exposures for which there is reliable information.'' This includes exposure through drinking water and in residential settings, but does not include occupational exposure. Pursuant to section 408(c)(2)(B) of FFDCA, in establishing or maintaining in effect an exemption from the requirement of a tolerance, EPA must take into account the factors set forth in section 408(b)(2)(C) of FFDCA, which require EPA to give special consideration to exposure of infants and children to the pesticide chemical residue in establishing a tolerance and to ``ensure that there is a reasonable certainty that no harm will result to infants and children from aggregate exposure to the pesticide chemical residue. . . .'' Additionally, section 408(b)(2)(D) of FFDCA requires that the Agency consider ``available information concerning the cumulative effects of a particular pesticide's residues'' and ``other substances that have a common mechanism of toxicity.''

EPA performs a number of analyses to determine the risks from aggregate
[[Page 15867]]
exposure to pesticide residues. First, EPA determines the toxicity of pesticides. Second, EPA examines exposure to the pesticide through food, drinking water, and through other exposures that occur as a result of pesticide use in residential settings.

III. Toxicological Profile

Consistent with section 408(b)(2)(D) of FFDCA, EPA has reviewed the available scientific data and other relevant information in support of this action and considered its validity, completeness, and reliability and the relationship of this information to human risk. EPA has also considered available information concerning the variability of the sensitivities of major identifiable subgroups of consumers, including infants and children.

Toxicological data on the active ingredient were previously submitted to support the existing exemption from the requirement of a tolerance for residues of Bacillus subtilis MBI 600 resulting from its use in the treatment of seeds used for growing agricultural crops, and to support various pesticide product registrations held by the petitioner. The previously submitted studies on the active ingredient include the following:

An acceptable acute oral toxicity/pathogenicity study performed in rats (MRID 41907402) demonstrated the lack of mammalian toxicity at high levels of exposure to Bacillus subtilis MBI 600. In this study, Bacillus subtilis MBI 600 was not toxic, infective nor pathogenic to rats given an oral dose of 2 x 10⁸ colony forming units (CFU) per animal. The study resulted in a classification of Toxicity Category IV for this strain of Bacillus subtilis.

An acceptable acute pulmonary toxicity/pathogenicity study in rats (MRID 41907404) demonstrated that Bacillus subtilis MBI 600 was neither toxic, pathogenic nor infective to rats dosed intratracheally with 3.4 x 10⁸ CFU of the test material. The study resulted in a classification of Toxicity Category IV for this strain of Bacillus subtilis.

An acceptable acute intravenous injection toxicity/pathogenicity study in rats (MRID 41907405) demonstrated that Bacillus subtilis MBI 600 was neither toxic, pathogenic nor infective to rats dosed intravenously with approximately 4 x 10⁷ CFU of the test material. Although the microbe was detected in every organ tested, the test material displayed a distinct pattern of clearance. The study resulted in a classification of Toxicity Category IV for this strain of Bacillus subtilis.

An acceptable acute dermal toxicity study in rabbits (MRID 419074 03) demonstrated that Bacillus subtilis MBI 600 was not toxic to rabbits when a single 5 x 10¹⁰ dose was administered dermally. The study resulted in a classification of Toxicity Category IV for this strain of Bacillus subtilis.

An acceptable primary eye irritation study in rabbits (MRID 419074 06) demonstrated that Bacillus subtilis MBI 600 produced a slight ocular irritation when a single 0.1 gram ocular dose was administered. Ocular irritation dissipated by day 4. The study resulted in a classification of Toxicity Category IV for this strain of Bacillus subtilis.

A supplemental skin sensitization test resulted in an overall moderate reaction in guinea pigs 24 to 78 hours posttreatment. However, an acceptable dermal sensitization study, conducted with an end use formulation, demonstrated no irritation 2 weeks after sensitization and treatment using 400 milligrams of test material. As a result, the product was determined to not be a dermal sensitizer. Furthermore, in the nearly 15 years since its initial registration as an active ingredient, there have been no hypersensitivity reports associated with Bacillus subtilis MBI 600 pesticide products. IV. Aggregate Exposures

In examining aggregate exposure, section 408 of FFDCA directs EPA to consider available information concerning exposures from the pesticide residue in food and all other nonoccupational exposures, including drinking water from ground water or surface water and exposure through pesticide use in gardens, lawns, or buildings (residential and other indoor uses).

A. Dietary Exposure

Bacillus subtilis MBI 600 is ubiquitous in the environment, especially in soils and agricultural environments (indeed, strain MBI 600 of Bacillus subtilis is a naturallyoccurring isolate of the genus Bacillus, originally isolated from faba beans grown at Nottingham University School of Agriculture in the United Kingdom). As a result, dietary exposure to background levels of the naturally occurring microbe likely is already occurring and likely will continue to occur. Because of its ubiquitous presence in the environment, the Agency expects there to be no increase in exposure to Bacillus subtilis MBI 600 resulting from the existing and proposed pesticidal uses when compared to existing exposure to background levels of Bacillus subtilis MBI 600.

1. Food. As discussed above, dietary exposure to the naturally occurring microbe likely is already occurring and likely will continue to occur. Notably, similar Bacillus subtilis strains are used internationally in the production of food grade products and in fermented foods in Japan and Thailand. Reports in the literature implicating Bacillus subtilis (as distinguished from the specific strain, Bacillus subtilis MBI 600, at issue in this action) in food borne illness do not describe any pathogen or toxin production, but rather simple spoilage from Bacillus subtilis growth in dough. Such lowquality dough would not be suitable for bread production by commercial bakeries and so the Agency considers this particular food exposure scenario to be unlikely and the risk to be negligible. The risk posed to adults, infants and children from foodrelated exposures to Bacillus subtilis MBI 600 is minimal due to the demonstrated lack of acute oral toxicity/pathogenicity associated with the microbial pesticide. Based on the evaluation of the submitted data, there are no dietary risks that exceed the Agency's level of concern.

2. Drinking water exposure. Because Bacillus subtilis MBI 600 is ubiquitous in the environment, exposure to the microbe through drinking water may already be occurring and likely will continue to occur. While the proposed and existing use sites do not include direct application to aquatic environments, the intended use of Bacillus subtilis MBI 600 is treatment of growing crops or seed for the control of plant disease. If such uses were to result in pesticide spray drift or runoff that were to reach surface or ground waters, there is the potential for human exposure to Bacillus subtilis MBI 600 residues, albeit greatly diluted, in drinking water. Municipal drinking water treatment processes and deep water wells, however, would both further reduce any such residues. More importantly, even if oral exposure to this ubiquitous microbe should occur through drinking water, due to its demonstrated lack of acute oral toxicity/pathogenicity, the Agency concludes that there is a reasonable certainty that no harm will result from such exposure.

B. Other NonOccupational Exposure

The pesticide uses of Bacillus subtilis MBI 600, both those currently allowed and the additional ones being established by this rule, are limited to commercial agricultural and horticultural settings. There are no residential uses. Nonetheless, because Bacillus subtilis MBI 600 is naturally occurring and ubiquitous in the environment, the potential for nondietary, nonoccupational exposure to
[[Page 15868]]
its residues for the general population, including infants and children, is likely since populations have probably been previously exposed (and likely will continue to be exposed) to background levels of the microbe. However, neither such common human exposures to Bacillus subtilis MBI 600 naturally present in soils, waters and plants, nor exposures associated with similar Bacillus subtilis strains used internationally in producing foodgrade products and fermented foods, have resulted in reports of disease or other effects. Finally, while the literature includes accounts of Bacillus subtilis infections in humans (which consistently are reported only in otherwise compromised individuals), those reports are most notable for their rare and exceptional nature.

EPA's evaluation of the required highdose Tier I acute toxicity and pathogenicity tests resulted in the assignment of Toxicity Category IV (least toxic), and determinations of not infective and not pathogenic, for all exposure routes. No toxicological end points of concern were identified. There are no dietary endpoints that exceed the Agency's Level of Concern (LOC). Therefore, the Agency has determined that any additional exposure to the microbe resulting from residues attributable to Bacillus subtilis MBI 600 pesticide use will not result in additional aggregate nonoccupational risk from dermal and inhalation exposures. This conclusion, based solely on nonoccupational exposures, is consistent with EPA's determination that no occupational risks exceed the Agency's LOC, meaning that even regular occupational exposures associated with this active ingredient pose negligible risk. V. Cumulative Effects

No mechanism of toxicity in mammals has been identified for Bacillus subtilis MBI 600. Therefore, no cumulative effect with other related organisms is anticipated. Because the available data demonstrate a lack of toxicity/pathogenicity potential for the active ingredient, adverse dietary effects are unlikely.
VI. Determination of Safety for U.S. Population, Infants and Children

FFDCA section 408(b)(2)(C), as amended by the Food Quality Protection Act (FQPA) of 1996, provides that EPA shall assess the available information about consumption patterns among infants and children, special susceptibility of infants and children to pesticide chemical residues, and the cumulative effects on infants and children of the residues and other substances with a common mechanism of toxicity. In addition, FFDCA section (b)(2)(C) also provides that EPA shall apply an additional tenfold margin of safety for infants and children in the case of threshold effects to account for prenatal and postnatal toxicity and the completeness of the database, unless EPA determines that a different margin of safety will be safe for infants and children.

Based on the acute toxicity information discussed in Unit III., EPA concludes that there is a reasonable certainty that no harm will result to the United States population, including infants and children, from aggregate exposure to residues of Bacillus subtilis MBI 600. This includes all anticipated dietary exposures and all other exposures for which there is reliable information. The Agency has arrived at this conclusion because the data available on Bacillus subtilis MBI 600 demonstrate a lack of toxicity/pathogenicity potential. Thus, there are no threshold effects of concern and, as a result, the Agency has concluded that the additional tenfold margin of safety for infants and children is unnecessary in this instance. Further, the need to consider consumption patterns, special susceptibility, and cumulative effects does not arise when dealing with pesticides with no demonstrated significant adverse effects.
VII. Other Considerations

A. Endocrine Disruptors

Bacillus subtilis MBI 600 is a ubiquitous organism in the environment that is nontoxic to mammals. To date, there is no evidence to suggest that Bacillus subtilis MBI 600 affects the immune system, functions in a manner similar to any known hormone, or that it acts as an endocrine disruptor. Indeed, the submitted toxicity/pathogenicity studies in rodents indicate that, following several routes of exposure, the immune system is intact and able to process and clear the active ingredient. Therefore, it is unlikely that this organism will have estrogenic or endocrine effects.

B. Analytical Method

The Agency is establishing an exemption from the requirement of a tolerance for residues of Bacillus subtilis MBI 600 in or on all food commodities, including residues resulting from postharvest uses, for the reasons stated above. Therefore, the Agency has concluded that an analytical method is not required for enforcement purposes for detecting Bacillus subtilis MBI 600 residues resulting from its use as a pesticide.

C. Codex Maximum Residue Level

No Codex maximum residue level (MRL) exists for Bacillus subtilis MBI 600.

VIII. Conclusions

Based on the toxicity information for Bacillus subtilis MBI 600 that was previously submitted and reviewed, EPA concludes that there is a reasonable certainty that no harm will result to the U.S. population, including infants and children, from aggregate exposure to Bacillus subtilis MBI 600 under reasonably foreseeable circumstances when used as a microbial pesticide in accordance with its label and good agricultural practices. This includes all anticipated dietary exposures and all other exposures for which there is reliable information. As a result, pursuant to FFDCA sections 408(c) and (d) EPA is establishing an exemption from the requirement of a tolerance for residues of the biofungicide Bacillus subtilis MBI 600 in or on all food commodities, including residues resulting from postharvest uses, when applied or used in accordance with good agricultural practices.

IX. Statutory and Executive Order Reviews

This final rule establishes a tolerance under section 408(d) of FFDCA in response to a petition submitted to the Agency. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866, entitled Regulatory Planning and Review (58 FR 51735, October 4, 1993). Because this final rule has been exempted from review under Executive Order 12866, this final rule is not subject to Executive Order 13211, entitled Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled Protection of Children from Environmental Health Risks and Safety Risks (62 FR 19885, April 23, 1997). This final rule does not contain any information collections subject to OMB approval under the Paperwork Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any special considerations under Executive Order 12898, entitled Federal Actions to Address Environmental Justice in Minority Populations and LowIncome Populations (59 FR 7629, February 16, 1994).

Since tolerances and exemptions that are established on the basis of a petition under section 408(d) of FFDCA, such as
[[Page 15869]]
the tolerance in this final rule, do not require the issuance of a proposed rule, the requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et seq.) do not apply.

This final rule directly regulates growers, food processors, food handlers, and food retailers, not States or tribes, nor does this action alter the relationships or distribution of power and responsibilities established by Congress in the preemption provisions of section 408(n)(4) of FFDCA. As such, the Agency has determined that this action will not have a substantial direct effect on States or tribal governments, on the relationship between the national government and the States or tribal governments, or on the distribution of power and responsibilities among the various levels of government or between the Federal Government and Indian tribes. Thus, the Agency has determined that Executive Order 13132, entitled Federalism (64 FR 43255, August 10, 1999) and Executive Order 13175, entitled Consultation and Coordination with Indian Tribal Governments (65 FR 67249, November 9, 2000) do not apply to this final rule. In addition, this final rule does not impose any enforceable duty or contain any unfunded mandate as described under Title II of the Unfunded Mandates Reform Act of 1995 (UMRA) (Public Law 1044).

This action does not involve any technical standards that would require Agency consideration of voluntary consensus standards pursuant to section 12(d) of the National Technology Transfer and Advancement Act of 1995 (NTTAA), Public Law 104113, section 12(d) (15 U.S.C. 272 note).

X. Congressional Review Act

The Congressional Review Act, 5 U.S.C. 801 et seq., generally provides that before a rule may take effect, the agency promulgating the rule must submit a rule report to each House of the Congress and to the Comptroller General of the United States. EPA will submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of this final rule in the Federal Register. This final rule is not a ``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and pests, Reporting and recordkeeping requirements.

Dated: March 20, 2009.
Janet L. Andersen,
Director, Biopesticides and Pollution Prevention Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180[AMENDED]
1. The authority citation for part 180 continues to read as follows:

Authority: 21 U.S.C. 321(q), 346a and 371.
2. Section 180.1128 is revised to read as follows:
Sec. 180.1128 Bacillus subtilis MBI 600; exemption from the requirement of a tolerance.

An exemption from the requirement of a tolerance is established for residues of the biofungicide Bacillus subtilis MBI 600 in or on all food commodities, including residues resulting from postharvest uses, when applied or used in accordance with good agricultural practices. [FR Doc. E97172 Filed 4709; 8:45 am]
BILLING CODE 656050S

FOR FURTHER INFORMATION CONTACT

Denise Greenway, Biopesticides and Pollution Prevention Division (7511P), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 204600001; telephone number: (703) 3088263; email address: greenway.denise@epa.gov.